OpenURL Connection Search

Select item for more details and to access through your institution.

Results of the first‐in‐human, randomized, double‐blind, placebo‐controlled phase 1b study of lumbar intrathecal bolus administrations of antisense oligonucleotide (ISIS 814907; BIIB080) targeting tau mRNA in patients with mild Alzheimer's disease
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051871
By:
- Mummery, Catherine J;
- Junge, Candice;
- Kordasiewicz, Holly B;
- Mignon, Laurence;
- Moore, Katrina M;
- Yun, Chris;
- Baumann, Tiffany L;
- Li, Dan;
- Norris, Daniel A;
- Crean, Rebecca;
- Graham, Danielle;
- Huang, Ellen;
- Ratti, Elena;
- Lane, Roger M
Publication type:
Article
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 5, p. 571, doi. 10.1016/j.jalz.2013.09.004
By:
- Rafii, Michael S.;
- Baumann, Tiffany L.;
- Bakay, Roy A.E.;
- Ostrove, Jeffrey M.;
- Siffert, Joao;
- Fleisher, Adam S.;
- Herzog, Christopher D.;
- Barba, David;
- Pay, Mary;
- Salmon, David P.;
- Chu, Yaping;
- Kordower, Jeffrey H.;
- Bishop, Kathie;
- Keator, David;
- Potkin, Steven;
- Bartus, Raymond T.
Publication type:
Article
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
Published in:
Annals of Neurology, 2015, v. 78, n. 2, p. 248, doi. 10.1002/ana.24436
By:
- Warren Olanow, C.;
- Bartus, Raymond T.;
- Baumann, Tiffany L.;
- Factor, Stewart;
- Boulis, Nicholas;
- Stacy, Mark;
- Turner, Dennis A.;
- Marks, William;
- Larson, Paul;
- Starr, Phillip A.;
- Jankovic, Joseph;
- Simpson, Richard;
- Watts, Ray;
- Guthrie, Barton;
- Poston, Kathleen;
- Henderson, Jaimie M.;
- Stern, Matthew;
- Baltuch, Gordon;
- Goetz, Christopher G.;
- Herzog, Christopher
Publication type:
Article

Found: 3

Results of the first‐in‐human, randomized, double‐blind, placebo‐controlled phase 1b study of lumbar intrathecal bolus administrations of antisense oligonucleotide (ISIS 814907; BIIB080) targeting tau mRNA in patients with mild Alzheimer's disease

A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.

Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.